Stone House Investment Management, LLC
Position in AQST — Aquestive Therapeutics, Inc.
CIK 1696497
TUNKHANNOCK, PA
Position in AQST
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$4,343
+$11 QoQ
Shares Held
1,044
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#164
of 184 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Stone House Investment Management, LLC holds $90,921 across 20 Drug Manufacturers - Specialty & Generic names. AQST ranks #7 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GLAS |
Glass House Brands Inc.
|
2,500 | $32,500 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
188 | $12,022 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
457 | $7,325 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
452 | $6,549 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
45 | $4,992 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
135 | $4,680 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
This page
|
1,044 | $4,343 | |
| 8 | HLN |
Haleon plc
|
450 | $4,198 |
All Filings in AQST
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,343 | 1,044 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $4,332 | 1,044 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $6,460 | 1,000 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $5,590 | 1,000 | Shares | Sole | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||